Researchers Use Robotic Surgery To Deliver Cardiac Stem Cell Therapy
Using stem cells and robotic surgical techniques, a team of university researchers has improved the function of pig hearts damaged in a way similar to what happens when a person has a heart attack.
Plans Under Way to Apply Stem Cell Therapy in Thailand
The Prasat Neurological Institute revealed yesterday it is planning to conduct clinical trials of stem-cell therapy to treat three major neural diseases for the first time in the country.
UK Doctors Use Stem Cells to Help Mend Broken Bones
A new way of promoting healing when fractured bones refuse to mend, has been pioneered at a British hospital, saving patients permanent disability or amputation.
Discovery in ‘Bubble Boy’ Disease Gene Therapy
Scientists at St. Jude Children’s Research Hospital have developed a mouse model of a severe disease of the immune system that helps explain why gene therapy used to treat children with this disease at an institution in Europe caused some of them to develop leukemia.
Medical University of South Carolina Researchers Test Possibility of Growing Kidneys for Transplant
Bioengineers from the Medical University of South Carolina and Clemson University believe their research has the potential to save the lives of thousands of patients desperately waiting for a kidney while, at the same time, cutting costs associated with kidney disease.
Malignant Melanoma Cells Secrete Protein Required for Embryo Formation
A Northwestern University research group has discovered that aggressive melanoma cells secrete Nodal, a protein that is critical to proper embryo formation.
Sunnybrook Researchers Identify Which Sets of Molecules are Required to Induce T Cells
Researchers at Sunnybrook Health Sciences Centre have made a critical discovery in T cell development bringing immunologists one step closer to enabling the creation of tailored T cell therapy that could one day be used to treat patients with AIDS or other immune system deficiencies.
Mapping System Tells Skin Cells Whether To Become Scalp, Palm Tissues
Global-positioning system aficionados know that it’s possible to precisely define any location in the world with just three geographic coordinates: latitude, longitude and altitude. Now scientists at the Stanford University School of Medicine have discovered that specialized skin cells use a similar mapping system to identify where they belong in the body and how to act once they arrive.
Biovest International Receives Positive Opinion on Application for Orphan Medicinal Product Designation by European Agency
Biovest International, Inc. has received official notification from the Committee on Orphan Medical Products (COMP) of the European Medicines Agency that a positive opinion was made regarding the application for orphan medicinal product designation for BiovaxID(TM) the company’s autologous immunotherapy for the treatment of follicular lymphoma in the European Union (EU).
Ortec’s FDA Approved Cell Line Plays Pivotal Role in Creation of First Embryonic Stem Cell Lines Fit for Human Clinical Trials
Ortec International, Inc. announced today that their collaboration with ES Cell International Pte, Ltd. (ESI), established in April 2004 in connection with the development of ESI’s human embryonic stem cell (hESC) derived cell therapy products, has yielded its first significant milestone.
Jury is Still Out on Worth of Stem Cell Treatment
Many thoroughbreds are being treated with stem cell treatment, but there is still speculation as to whether it is a wonder cure.
ABSTRACTS, REVIEWS & SPECIAL REPORTS
T Lineage Differentiation from Human Embryonic Stem Cells
Using sequential in vitro coculture on murine bone marrow stromal cells, and engraftment into human thymic tissues in immunodeficient mice, the researchers demonstrate that hESC can differentiate through the T lymphoid lineage.
Unique Risk Factors for Insertional Mutagenesis in a Mouse Model of XSCID Gene Therapy
The researchers have developed a model that should be useful for testing safety-modified vectors and for further exploring the risk factors leading to insertional mutagenesis in gene therapy trials.